COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
NCT04498273
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
657
Enrollment
OTHER
Sponsor class
Stopped
an event rate lower than anticipated
Conditions
COVID-19
Interventions
DRUG:
Apixaban 2.5 MG
DRUG:
Apixaban 5MG
DRUG:
Aspirin
DRUG:
Placebo
Sponsor
Frank C Sciurba
Collaborators
[object Object]